A federal court has granted a preliminary injunction to drugmaker Johnson & Johnson that prohibits rival Mylan Laboratories Inc. from launching a generic formula of Topamax. Mylan won approval in September to begin selling a generic formula of the popular migraine and epilepsy treatment. The injunction will prevent the generic from immediately going to market.
Read moreMylan Pharmaceuticals has received tentative approval from the FDA to sell a generic version of Depakote ER, owned by Abbott Laboratories.... Read more »
One of our forum members asked today if Stadol Masal Spray has been discontinued because her pharmacist had notified her that it was and he... Read more »
For all of you who are using Topamax for Migraine and headache prevention, there's good news. Generic topiramate has been approved by the... Read more »
According to generic drugmaker Mylan, the U.S. Food and Drug Administration (FDA) has approved their generic version of the migraine med Imitrex. The... Read more »
Mylan Labs has been banned from selling a generic version of Topamax until the patent expires in 2008. A U.S. district court ruled against the... Read more »
Mylan Pharmaceuticals has received tentative approval from the Food and Drug Administration to sell generic Topamax. Ortho-McNeil's patent for... Read more »
The Food and Drug Administration has approved a generic version of the bronchodilator VoSpire ER. VoSpire is approved for the treatment of... Read more »
A U.S. District Court has blocked all generic versions of Norvasc except for those made by Mylan until April 13, 2007. But now Pfizer--which makes... Read more »